Table 2.
Response to treatment (n/%).
| Response | Investigator assessment (%) |
|---|---|
| CR* | 3 (21.4) |
| PR* | 4 (28.6) |
| SD* | 4 (28.6) |
| PD* | 3 (21.4) |
| ORR* (CR or PR) | 7 (50.0) |
| DCR* (CR, PR, or SD) | 11 (78.6) |
| Median PFS*, months (95% CI)* | 10.8 M (0.23.5) |
| Median OS*, months (95% CI) | 19.3 M (2.4, 36.2) |
| Median DE* (range) | 6.4 M(4.0, 8.9) |
*CR, complete response; PR, partial response; SD,stable disease; PD, Progressive disease; ORR, overall response rate; DCR, disease control rate; PFS, progression-free survival; OS, overall survival; DE, duration of exposure; CI, confidence interval.